Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma

Gertruda Evaristo; Pierre-Oliver Fiset; Sophie Camilleri-Broët; Tsafrir Vanounou; Petr Kavan; Alan Spatz; Hangjun Wang

doi:10.1097/PAS.0000000000001483

Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma

Am J Surg Pathol. 2020 Sep;44(9):1290-1292. doi: 10.1097/PAS.0000000000001483.

Authors

Gertruda Evaristo¹, Pierre-Oliver Fiset^{1

2}, Sophie Camilleri-Broët^{1

2}, Tsafrir Vanounou^{3

4}, Petr Kavan⁴, Alan Spatz^{1

2

4

5}, Hangjun Wang^{1

2

5}

Affiliations

¹ Department of Pathology.
² Division of Pathology and Molecular Genetics, McGill University Health Centre.
³ Division of General Surgery.
⁴ Departments of Oncology.
⁵ Medicine and Lady Davis Institute Jewish General Hospital Montreal, QC, Canada.

PMID: 32452871
DOI: 10.1097/PAS.0000000000001483

No abstract available

Publication types

Comment

MeSH terms

Humans
Lung Neoplasms*
Mesothelioma*
Neurofibromatosis 2*
Peritoneal Neoplasms*